The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES

Abstract Background Atherogenic index of plasma (AIP), a marker of atherosclerosis and cardiovascular disease (CVD), was related to the all-cause mortality and CVD-specific mortality in a U-shape in general population respectively. However, no studies have investigated these associations in hyperten...

Full description

Bibliographic Details
Main Authors: Gulinuer duiyimuhan, Nuerguli Maimaiti
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-023-03451-0
_version_ 1797453979892842496
author Gulinuer duiyimuhan
Nuerguli Maimaiti
author_facet Gulinuer duiyimuhan
Nuerguli Maimaiti
author_sort Gulinuer duiyimuhan
collection DOAJ
description Abstract Background Atherogenic index of plasma (AIP), a marker of atherosclerosis and cardiovascular disease (CVD), was related to the all-cause mortality and CVD-specific mortality in a U-shape in general population respectively. However, no studies have investigated these associations in hypertensive populations. Herein, this study aims to explore the relationship of AIP and all-cause mortality and CVD-specific mortality in patients with hypertension in order to provide some reference for the risk hierarchical management of hypertension. Methods Demographic and clinical data of 17,382 adult patients with hypertension were extracted from the National Health and Nutrition Examination Survey (NHANES) database in 2005–2018 in this retrospective cohort study. We used weighted univariate COX regression analysis to screen the covariates, and that weighted univariate and multivariate COX regression analyses to explore the association between AIP and all-cause mortality and CVD-specific mortality with hazard ratios (HRs) and 95% confidence intervals (CIs). Subgroup analyses of age, gender, body mass index (BMI), CVD, diabetes mellitus (DM), antihyperlipidemic agents use, and hypotensive drugs use were also performed for further exploration of these relationships. Results The average follow-up time was 97.10 months. A total of 2,844 patients died, and 971 of them died due to CVD. After adjusting for age, race, education level, marital status, poverty-income ratio (PIR), smoking, BMI, physical activity, antihyperlipidemic agents, DM, CVD, hypotensive drugs, estimated glomerular filtration rate (eGFR), and total energy intake, we found that both low [HR = 1.18, 95%CI: (1.07–1.32)] and high [HR = 1.17, 95%CI: (1.03–1.33)] levels of AIP were linked to an increased risk of all-cause mortality, and the U-shape association between AIP and CVD-specific mortality was also found [low AIP level: HR = 1.26, 95%CI: (1.05–1.51); high AIP level: HR = 1.26, 95%CI: (1.06–1.49)]. Furthermore, these relationships were existed in patients whose BMI > 25, were non-Hispanic White, with non-CVD, non-DM, non-antihyperlipidemic agents, and used hypertension drug (all P < 0.05). Conclusion AIP was associated with both all-cause mortality and CVD-specific mortality in patients with hypertension, but the specific role of AIP in prognosis in hypertensive populations is needed further exploration.
first_indexed 2024-03-09T15:30:41Z
format Article
id doaj.art-e69e8441966c4a039dfd498d206ab466
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-03-09T15:30:41Z
publishDate 2023-09-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-e69e8441966c4a039dfd498d206ab4662023-11-26T12:16:52ZengBMCBMC Cardiovascular Disorders1471-22612023-09-0123111310.1186/s12872-023-03451-0The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANESGulinuer duiyimuhan0Nuerguli Maimaiti1Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous RegionHypertension Center of People’s Hospital of Xinjiang Uygur Autonomous RegionAbstract Background Atherogenic index of plasma (AIP), a marker of atherosclerosis and cardiovascular disease (CVD), was related to the all-cause mortality and CVD-specific mortality in a U-shape in general population respectively. However, no studies have investigated these associations in hypertensive populations. Herein, this study aims to explore the relationship of AIP and all-cause mortality and CVD-specific mortality in patients with hypertension in order to provide some reference for the risk hierarchical management of hypertension. Methods Demographic and clinical data of 17,382 adult patients with hypertension were extracted from the National Health and Nutrition Examination Survey (NHANES) database in 2005–2018 in this retrospective cohort study. We used weighted univariate COX regression analysis to screen the covariates, and that weighted univariate and multivariate COX regression analyses to explore the association between AIP and all-cause mortality and CVD-specific mortality with hazard ratios (HRs) and 95% confidence intervals (CIs). Subgroup analyses of age, gender, body mass index (BMI), CVD, diabetes mellitus (DM), antihyperlipidemic agents use, and hypotensive drugs use were also performed for further exploration of these relationships. Results The average follow-up time was 97.10 months. A total of 2,844 patients died, and 971 of them died due to CVD. After adjusting for age, race, education level, marital status, poverty-income ratio (PIR), smoking, BMI, physical activity, antihyperlipidemic agents, DM, CVD, hypotensive drugs, estimated glomerular filtration rate (eGFR), and total energy intake, we found that both low [HR = 1.18, 95%CI: (1.07–1.32)] and high [HR = 1.17, 95%CI: (1.03–1.33)] levels of AIP were linked to an increased risk of all-cause mortality, and the U-shape association between AIP and CVD-specific mortality was also found [low AIP level: HR = 1.26, 95%CI: (1.05–1.51); high AIP level: HR = 1.26, 95%CI: (1.06–1.49)]. Furthermore, these relationships were existed in patients whose BMI > 25, were non-Hispanic White, with non-CVD, non-DM, non-antihyperlipidemic agents, and used hypertension drug (all P < 0.05). Conclusion AIP was associated with both all-cause mortality and CVD-specific mortality in patients with hypertension, but the specific role of AIP in prognosis in hypertensive populations is needed further exploration.https://doi.org/10.1186/s12872-023-03451-0AIPAll-cause mortalityCVD-specific mortalityNHANES
spellingShingle Gulinuer duiyimuhan
Nuerguli Maimaiti
The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES
BMC Cardiovascular Disorders
AIP
All-cause mortality
CVD-specific mortality
NHANES
title The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES
title_full The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES
title_fullStr The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES
title_full_unstemmed The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES
title_short The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES
title_sort association between atherogenic index of plasma and all cause mortality and cardiovascular disease specific mortality in hypertension patients a retrospective cohort study of nhanes
topic AIP
All-cause mortality
CVD-specific mortality
NHANES
url https://doi.org/10.1186/s12872-023-03451-0
work_keys_str_mv AT gulinuerduiyimuhan theassociationbetweenatherogenicindexofplasmaandallcausemortalityandcardiovasculardiseasespecificmortalityinhypertensionpatientsaretrospectivecohortstudyofnhanes
AT nuergulimaimaiti theassociationbetweenatherogenicindexofplasmaandallcausemortalityandcardiovasculardiseasespecificmortalityinhypertensionpatientsaretrospectivecohortstudyofnhanes
AT gulinuerduiyimuhan associationbetweenatherogenicindexofplasmaandallcausemortalityandcardiovasculardiseasespecificmortalityinhypertensionpatientsaretrospectivecohortstudyofnhanes
AT nuergulimaimaiti associationbetweenatherogenicindexofplasmaandallcausemortalityandcardiovasculardiseasespecificmortalityinhypertensionpatientsaretrospectivecohortstudyofnhanes